JP2022538475A5 - - Google Patents
Info
- Publication number
- JP2022538475A5 JP2022538475A5 JP2021578186A JP2021578186A JP2022538475A5 JP 2022538475 A5 JP2022538475 A5 JP 2022538475A5 JP 2021578186 A JP2021578186 A JP 2021578186A JP 2021578186 A JP2021578186 A JP 2021578186A JP 2022538475 A5 JP2022538475 A5 JP 2022538475A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding protein
- seq
- group
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025072533A JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962870232P | 2019-07-03 | 2019-07-03 | |
| US62/870,232 | 2019-07-03 | ||
| US202063020177P | 2020-05-05 | 2020-05-05 | |
| US63/020,177 | 2020-05-05 | ||
| US202063021826P | 2020-05-08 | 2020-05-08 | |
| US63/021,826 | 2020-05-08 | ||
| PCT/US2020/040642 WO2021003357A1 (en) | 2019-07-03 | 2020-07-02 | Anti-new york esophageal squamous cell carcinoma 1 (ny-eso-1) antigen-binding proteins and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072533A Division JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538475A JP2022538475A (ja) | 2022-09-02 |
| JP2022538475A5 true JP2022538475A5 (https=) | 2023-07-10 |
| JP7674278B2 JP7674278B2 (ja) | 2025-05-09 |
Family
ID=74101175
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021578186A Active JP7674278B2 (ja) | 2019-07-03 | 2020-07-02 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
| JP2025072533A Pending JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072533A Pending JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12600783B2 (https=) |
| EP (1) | EP3993817A4 (https=) |
| JP (2) | JP7674278B2 (https=) |
| KR (1) | KR20220042137A (https=) |
| CN (2) | CN114302733B (https=) |
| AU (1) | AU2020301027A1 (https=) |
| BR (1) | BR112021026831A2 (https=) |
| CA (1) | CA3145857A1 (https=) |
| CL (1) | CL2021003550A1 (https=) |
| CO (1) | CO2022000804A2 (https=) |
| IL (1) | IL289573A (https=) |
| MA (1) | MA56468A (https=) |
| MX (1) | MX2022000081A (https=) |
| PH (1) | PH12021553306A1 (https=) |
| WO (1) | WO2021003357A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12022500012A1 (en) | 2020-03-30 | 2023-04-03 | Daiichi Sankyo Co Ltd | Bispecific antibody |
| US20250195645A1 (en) * | 2022-03-16 | 2025-06-19 | Daiichi Sankyo Company, Limited | Combination of multispecific molecule and immune checkpoint inhibitor |
| CN116970614A (zh) * | 2022-12-29 | 2023-10-31 | 达冕疫苗(广州)有限公司 | 编码ny-eso-1的核糖核酸疫苗的组合物和方法 |
| JP2026507123A (ja) | 2023-02-28 | 2026-02-27 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ｔ細胞活性化剤およびその使用方法 |
| CN117843794A (zh) * | 2023-12-01 | 2024-04-09 | 浙江大学 | 一种抗ny-eso-1的纳米抗体及其应用 |
| WO2026006794A1 (en) * | 2024-06-27 | 2026-01-02 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric antigen receptors and uses thereof |
| CN119161418B (zh) * | 2024-08-30 | 2025-11-21 | 天津大学 | 一种结合ny-eso-1抗原的蛋白 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1061623A (zh) * | 1990-06-01 | 1992-06-03 | 里珍纳龙药品有限公司 | 睫状神经营养性因子受体 |
| AU2003217384A1 (en) * | 2002-02-13 | 2003-09-04 | Ludwig Institute For Cancer Research | Isolated peptides which bind to hla molecules and uses thereof |
| US8193318B2 (en) * | 2002-08-14 | 2012-06-05 | Macrogenics, Inc. | FcγRIIB specific antibodies and methods of use thereof |
| ATE417065T1 (de) * | 2004-05-19 | 2008-12-15 | Medigene Ltd | Hochaffiner ny-eso-t-zellen-rezeptor |
| EP2457928B1 (en) | 2007-03-13 | 2017-05-10 | Universität Zürich | Monoclonal human tumor-specific antibody |
| WO2010106431A2 (en) * | 2009-03-20 | 2010-09-23 | Ludwig Institute For Cancer Research Ltd | High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof |
| WO2010141986A1 (en) * | 2009-06-09 | 2010-12-16 | Mabdesign Pty Ltd | Novel antibodies and uses therefor |
| EP3404111A1 (en) * | 2013-03-13 | 2018-11-21 | Health Research, Inc. | Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen |
| CN104450615B (zh) * | 2013-09-25 | 2020-12-15 | 深圳市北科生物科技有限公司 | 一种具有双特异性抗体的细胞CTL(BiAT)及其制备方法与应用 |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| JP2017529841A (ja) | 2014-09-19 | 2017-10-12 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | キメラ抗原受容体 |
| AU2016274767B2 (en) * | 2015-06-09 | 2022-05-19 | Eureka Therapeutics, Inc. | T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA |
| HK1248255A1 (zh) | 2015-06-24 | 2018-10-12 | 优瑞科生物技术公司 | 靶向ny-eso-1肽/mhc复合物的构建体及其用途 |
| CN106729698A (zh) * | 2015-11-25 | 2017-05-31 | 宁波美丽人生医药生物科技发展有限公司 | NY-ESO-1有作为增强Art v1(wtArt)过敏原免疫反应分子佐剂的作用 |
| WO2017111862A1 (en) | 2015-12-23 | 2017-06-29 | Xiaolin Ai | Multimode electromechanical variable speed transmission apparatus with smooth mode shifting and method of controlling the same |
| JP2018013957A (ja) * | 2016-07-21 | 2018-01-25 | 東芝テック株式会社 | 読取装置、サーバ装置、及びプログラム |
| JP2020503883A (ja) * | 2017-01-13 | 2020-02-06 | アジェナス インコーポレイテッド | Ｎｙ−ｅｓｏ−１に結合するｔ細胞受容体およびその使用方法 |
| KR102104551B1 (ko) * | 2017-05-11 | 2020-04-24 | (주)온코태그디아그노스틱 | Mrs에 특이적으로 결합하는 모노클로날 항체 |
| EA202090149A1 (ru) * | 2017-06-28 | 2020-05-31 | Ридженерон Фармасьютикалз, Инк. | Антигенсвязывающие белки против вируса папилломы человека (hpv) и способы их применения |
| WO2019084538A1 (en) | 2017-10-27 | 2019-05-02 | Board Of Regents, The University Of Texas System | TUMOR SPECIFIC ANTIBODIES, T CELL RECEPTORS AND METHODS OF IDENTIFICATION THEREOF |
| CN108383908A (zh) * | 2018-02-05 | 2018-08-10 | 昆山百尔泰生物科技有限公司 | 识别人源ctla-4并阻断其功能的全人源单克隆抗体或抗体片段及其制备方法和用途 |
| EP4004049A1 (en) | 2019-07-24 | 2022-06-01 | Regeneron Pharmaceuticals, Inc. | Chimeric antigen receptors with mage-a4 specificity and uses thereof |
| PH12022500012A1 (en) * | 2020-03-30 | 2023-04-03 | Daiichi Sankyo Co Ltd | Bispecific antibody |
| KR20230025662A (ko) * | 2020-05-05 | 2023-02-22 | 리제너론 파마슈티칼스 인코포레이티드 | Cd28 제타 및 cd3 제타를 포함하는 car |
-
2020
- 2020-07-02 JP JP2021578186A patent/JP7674278B2/ja active Active
- 2020-07-02 CN CN202080061474.0A patent/CN114302733B/zh active Active
- 2020-07-02 BR BR112021026831A patent/BR112021026831A2/pt unknown
- 2020-07-02 US US17/622,307 patent/US12600783B2/en active Active
- 2020-07-02 AU AU2020301027A patent/AU2020301027A1/en active Pending
- 2020-07-02 MA MA056468A patent/MA56468A/fr unknown
- 2020-07-02 KR KR1020227003658A patent/KR20220042137A/ko active Pending
- 2020-07-02 PH PH1/2021/553306A patent/PH12021553306A1/en unknown
- 2020-07-02 CA CA3145857A patent/CA3145857A1/en active Pending
- 2020-07-02 MX MX2022000081A patent/MX2022000081A/es unknown
- 2020-07-02 EP EP20835029.8A patent/EP3993817A4/en active Pending
- 2020-07-02 CN CN202510427533.6A patent/CN120248123A/zh active Pending
- 2020-07-02 WO PCT/US2020/040642 patent/WO2021003357A1/en not_active Ceased
-
2021
- 2021-12-29 CL CL2021003550A patent/CL2021003550A1/es unknown
-
2022
- 2022-01-02 IL IL289573A patent/IL289573A/en unknown
- 2022-01-28 CO CONC2022/0000804A patent/CO2022000804A2/es unknown
-
2025
- 2025-04-24 JP JP2025072533A patent/JP2025156298A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022538475A5 (https=) | ||
| JP7611171B2 (ja) | 抗ｒｏｒ１／抗ｃｄ３二重特異性結合分子 | |
| JP2020529835A5 (https=) | ||
| TWI821474B (zh) | Ｃｄ３抗體及其藥物用途 | |
| IL299348B1 (en) | Antigen-binding proteins against human papillomavirus and methods of using them | |
| JP2021508469A5 (https=) | ||
| WO2018147245A1 (ja) | 抗ｇｐｒｃ５ｄ抗体及び該抗体を含む分子 | |
| JP2020528750A5 (https=) | ||
| JP2020501531A5 (https=) | ||
| JP2019524693A5 (https=) | ||
| TW202438522A (zh) | 抗ｈｌａ－ｇ抗體、包含抗ｈｌａ－ｇ抗體之組成物及使用抗ｈｌａ－ｇ抗體之方法 | |
| JP2018503380A5 (https=) | ||
| CN111148761A (zh) | 多特异性抗体及其制备和使用方法 | |
| JP2017535257A5 (https=) | ||
| AU2020390028B2 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
| CN116948035A (zh) | 多特异性抗体及其制备和使用方法 | |
| JP7392145B2 (ja) | 免疫療法のためのｔ細胞二重特異性抗体の作製における最適化された抗ｃｄ３アーム | |
| JP2020515277A5 (https=) | ||
| JP2022526841A5 (https=) | ||
| JP2024515560A5 (https=) | ||
| TW202327649A (zh) | Ｐｖｒｉｇ／ｔｉｇｉｔ結合蛋白聯合免疫檢查點抑制劑用於治療癌症 | |
| WO2022095970A1 (zh) | 双特异抗体及其应用 | |
| JP2025503513A (ja) | Ｃｄ３を標的にする抗体、多特異性抗体、およびその使用 | |
| JP2023504733A (ja) | 抗ｃｌｅｃ－１ａ抗体及びその抗原結合性断片 | |
| WO2025016459A1 (zh) | 一种抗fgfr2/pd-1双特异性抗体 |